- Home
- CRVS vs HYT Comparison
CRVS vs HYT Comparison
Compare CRVS & HYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRVS | HYT |
|---|---|---|
| Founded | 2014 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRVS | HYT |
|---|---|---|
| Price | $14.09 | $8.35 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $28.20 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 926.3K |
| Earning Date | 03-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.61% |
| EPS Growth | ★ 48.04 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.54 | $7.84 |
| 52 Week High | $26.95 | $9.88 |
Technical Indicators
Market Signals| Indicator | CRVS | HYT |
|---|---|---|
| Relative Strength Index (RSI) | 40.37 | 30.12 |
| Support Level | $6.65 | N/A |
| Resistance Level | $18.73 | $8.98 |
| Average True Range (ATR) | 0.95 | 0.09 |
| MACD | -0.21 | -0.02 |
| Stochastic Oscillator | 27.18 | 1.23 |
Price Performance
Historical ComparisonAbout CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About HYT Blackrock Corporate High Yield Fund Inc.
BlackRock Corporate High Yield Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide shareholders with current income and capital appreciation. The trust's secondary investment objective is to provide shareholders with capital appreciation. It seeks to achieve its objectives by investing in a diversified portfolio of fixed-income securities.